Information for "Moderate COVID19 Symptoms in the Gefitinib ZD1839Treated Ulcerative Colitis Individual Can Ongoing AntiTNF Remedy Force away the actual Viral Hyperinflammatory Result and get away from Aggravated Final results"
From EECH Central
Basic information
| Display title | Moderate COVID19 Symptoms in the Gefitinib ZD1839Treated Ulcerative Colitis Individual Can Ongoing AntiTNF Remedy Force away the actual Viral Hyperinflammatory Result and get away from Aggravated Final results |
| Default sort key | Moderate COVID19 Symptoms in the Gefitinib ZD1839Treated Ulcerative Colitis Individual Can Ongoing AntiTNF Remedy Force away the actual Viral Hyperinflammatory Result and get away from Aggravated Final results |
| Page length (in bytes) | 3,327 |
| Page ID | 11722 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Thumbmenu61 (Talk | contribs) |
| Date of page creation | 08:12, 28 March 2023 |
| Latest editor | Thumbmenu61 (Talk | contribs) |
| Date of latest edit | 08:12, 28 March 2023 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
